Results 231 to 240 of about 88,387 (345)

Points from Letters: Blood Levels of Anticonvulsants [PDF]

, 1974
AnneE. Mccandless
openalex   +1 more source

Viloxazine and anticonvulsants. [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1985
openaire   +3 more sources

The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy. [PDF]

Biomolecules
Jackson K, Shabat-Simon M, Bar-On J, Steckler R, Khatib S, Tamir S, Pitashny PA.   +6 more
europepmc   +1 more source

Letter: Plasma levels of antidepressants and anticonvulsants. [PDF]

, 1975
E. H. Reynolds
openalex   +1 more source

Adropin ameliorates behavioral seizures and the relevant neuroinflammation, oxidative stress, and neural damage in a rat model of pentylenetetrazole-induced seizure potentially by reducing the activation of NF-κB/IkB-α signaling pathway. [PDF]

Metab Brain Dis
Namulodi S, Torun IE, Bayiroglu F, Kaya MS, Kilinc E.   +4 more
europepmc   +1 more source

Book Review: Anticonvulsant Therapy: Pharmacological Basis and Practice [PDF]

, 1975
M D O’Brien
openalex   +1 more source

Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders

Medicinal Research Reviews, EarlyView.
ABSTRACT Neuropsychiatric disorders present a multifaceted challenge, characterized by cognitive, social, and motor impairments with manifold underlying mechanisms. Recent attention has turned to epigenetic mechanisms, particularly histone lysine methyltransferases (HKMTs), such as G9a, in understanding fundamental pathogenesis.
Malak Hajar, Tobias Werner, Mihajlo Gajic, Holger Stark, Bassem Sadek   +4 more
wiley   +1 more source

Molecular mechanisms of neuroprotective effect of rutin. [PDF]

Front Pharmacol
Chunmei Z, Shuai W.
europepmc   +1 more source

Potential Anticonvulsant Drugs-I Synthesis of Substituted-𝛾-Aminobutyrophenones [PDF]

, 1974
VINAY S. MISRA, SHIVA PRAKASH
openalex   +1 more source

Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Pain is a recognized symptom of muscular dystrophy (MD), but little is known about prescription pain medications in this population. We describe pain experiences and pain medications prescribed for individuals with selected MDs using population‐based surveillance data collected by the Muscular Dystrophy Surveillance, Tracking,
Jonathan Suhl, Kristin M. Conway, Shiny Thomas, Sonja A. Rasmussen, James F. Howard, Nicholas E. Johnson, Paul A. Romitti, Katherine D. Mathews, The Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet)   +9 more
wiley   +1 more source